Fortress Biotech, Inc.
FBIO
$2.29
$0.073.15%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -167.30% | -62.22% | 246.32% | -56.45% | 47.42% |
| Total Depreciation and Amortization | 0.00% | 0.09% | -2.94% | 5.87% | 17.55% |
| Total Amortization of Deferred Charges | 6.27% | -29.27% | 52.88% | -1.67% | -22.88% |
| Total Other Non-Cash Items | 107.88% | 76.49% | -406.01% | -308.12% | 38.08% |
| Change in Net Operating Assets | -138.36% | 33.12% | -127.45% | 48.02% | -2.82% |
| Cash from Operations | -105.30% | 77.83% | -40.88% | -51.57% | 35.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -52.84% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -52.84% | 422.40% | 107.77% | -- |
| Total Debt Issued | -- | -- | -- | -- | -85.14% |
| Total Debt Repaid | 142.31% | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -77.16% | 191.91% | -45.07% | 66.91% | -91.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | 23.33% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.89% | 233.45% | -92.24% | 149.54% | 154.07% |
| Cash from Financing | -62.14% | 233.38% | -91.33% | 102.05% | 851.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.78% | 169.79% | -150.24% | 1,706.09% | 87.89% |